Advertisement

The maximum possible amount of drug in rapidly separating microneedles

  • Dan Dan Zhu
  • Xiao Peng Zhang
  • Chang Bing Shen
  • Yong CuiEmail author
  • Xin Dong GuoEmail author
Original Article
  • 49 Downloads

Abstract

There is an increasing concern on the drug loading capacity of microneedles (MNs) to meet higher drug dosage requirement. The present study describes the fabrication of modified rapidly separating polyvinyl alcohol (PVA)-based MNs (RS-P-MNs) with high drug loading using a mechanical agitation process. The drugs encapsulated within the PVA polymer gel by mechanical agitation served as an encapsulating agent for drugs that provide a high drug loading capacity and also release of drugs in a controlled manner. The various parameters such as microscopic analysis, atomic force microscopy (AFM), drug loading, drug delivery efficiency, mechanical test, skin penetration ability, and in vitro and in vivo analyses indicate the great potential of the RS-P-MNs. The maximum drug loading capacity of RS-P-MNs was measured to be approximately 900 ng per microneedle, which was almost a hundred times than the traditional drug encapsulating mode. The in vitro and in vivo results suggested that the controlled release of drugs is due to the encapsulating mode (mechanical agitation) of drugs. The prepared RS-P-MNs with high drug loading in this study provided a gentle and controlled release of drugs instead of the robust release of drugs from traditional MNs.

Graphical abstract

Keywords

Microneedle Polymers Controlled release Rapidly separating 

Notes

Funding

This work was financially supported by the National Natural Science Foundation of China (51673019, 51873015), the Fundamental Research Funds for the Central Universities and Research projects on biomedical transformation of China-Japan Friendship Hospital (PYBZ1817), and the long-term subsidy mechanism from the Ministry of Finance and the Ministry of Education of PRC.

Compliance with ethical standards

All the animal studies were conducted in accordance with the guidelines of the Ethics Committee of Beijing University of Chemical Technology (BUCT), Beijing, China.

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Garland MJ, Migalska K, Mazlelaa T, Mahmood T, Raghu T, Singh R, et al. Microneedle arrays as medical devices for enhanced transdermal drug delivery. Expert Rev Med Devices. 2011;8:459–82.CrossRefGoogle Scholar
  2. 2.
    Donnelly RF, Singh TRR, Tunney MM, Morrow DIJ, McCarron PA, O’Mahony C, et al. Microneedle arrays allow lower microbial penetration than hypodermic needles in vitro. Pharm Res. 2009;26:2513–22.CrossRefGoogle Scholar
  3. 3.
    Van der Maaden K, Jiskoot W, Bouwstra J. Microneedle technologies for (trans)dermal drug and vaccine delivery. J Control Release. 2012;161:645–55.CrossRefGoogle Scholar
  4. 4.
    Weldon WC, Martin MP, Zarnitsyn V, Wang BZ, Koutsonanos D, Skountzou I, et al. Microneedle vaccination with stabilized recombinant influenza virus hemagglutinin induces improved protective immunity. Clin Vaccine Immunol. 2011;18:647–54.CrossRefGoogle Scholar
  5. 5.
    Song JM, Kim YC, Lipatov AS, Pearton M, Davis CT, Yoo DG, et al. Microneedle delivery of H5N1 influenza virus-like particles to the skin induces long-lasting B- and T-cell responses in mice. Clin Vaccine Immunol. 2010;17:1381–9.CrossRefGoogle Scholar
  6. 6.
    Ito Y, Hagiwara E, Saeki A, Sugioka N, Takada K. Feasibility of microneedles for percutaneous absorption of insulin. Eur J Pharm Sci. 2006;29:82–8.CrossRefGoogle Scholar
  7. 7.
    Lee SG, Jeong JH, Lee KM, Jeong KH, Yang H, Kim M, et al. Nanostructured lipid carrier-loaded hyaluronic acid microneedles for controlled dermal delivery of a lipophilic molecule. Int J Nanomedicine. 2014;9:289–99.Google Scholar
  8. 8.
    Gill HS, Soderholm J, Prausnitz MR, Sallberg M. Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine. Gene Ther. 2010;17:811–4.CrossRefGoogle Scholar
  9. 9.
    Bariya SH, Gohel MC, Mehta TA, Sharma OP. Microneedles: an emerging transdermal drug delivery system. J Pharm Pharmacol. 2012;64:11–29.CrossRefGoogle Scholar
  10. 10.
    Escobar-Chavez JJ, Bonilla-Martinez D, Villegas-Gonzalez MA, Molina-Trinidad E, Casas-Alancaster N, Revilla-Vazquez AL. Microneedles: a valuable physical enhancer to increase transdermal drug delivery. J Clin Pharmacol. 2011;51:964–77.CrossRefGoogle Scholar
  11. 11.
    Banga AK. Microporation applications for enhancing drug delivery. Expert Opin Drug Del. 2009;6:343–54.CrossRefGoogle Scholar
  12. 12.
    Norman JJ, Brown MR, Raviele NA, Prausnitz MR, Felner EI. Faster pharmacokinetics and increased patient acceptance of intradermal insulin delivery using a single hollow microneedle in children and adolescents with type 1 diabetes. Pediatr Diabetes. 2013;14:459–65.CrossRefGoogle Scholar
  13. 13.
    Norman JJ, Choi SO, Tong NT, Aiyar AR, Patel SR, Prausnitz MR, et al. Hollow microneedles for intradermal injection fabricated by sacrificial micromolding and selective electrodeposition. Biomed Microdevices. 2013;15:203–10.CrossRefGoogle Scholar
  14. 14.
    Gill HS, Prausnitz MR. Coated microneedles for transdermal delivery. J Control Release. 2007;117:227–37.CrossRefGoogle Scholar
  15. 15.
    Ito Y, Taniguchi M, Hayashi A, Anai M, Morita S, Ko E, et al. Application of dissolving microneedles to glucose monitoring through dermal interstitial fluid. Biol Pharm Bull. 2014;37:1776–81.CrossRefGoogle Scholar
  16. 16.
    DeMuth PC, Garcia-Beltran WF, Ai-Ling ML, Hammond PT, Irvine DJ. Composite dissolving microneedles for coordinated control of antigen and adjuvant delivery kinetics in transcutaneous vaccination. Adv Funct Mater. 2013;23:161–72.CrossRefGoogle Scholar
  17. 17.
    Hirobe S, Azukizawa H, Matsuo K, Zhai Y, Quan YS, Kamiyama F, et al. Development and clinical study of a self-dissolving microneedle patch for transcutaneous immunization device. Pharm Res. 2013;30:2664–74.CrossRefGoogle Scholar
  18. 18.
    Ling MH, Chen MC. Dissolving polymer microneedle patches for rapid and efficient transdermal delivery of insulin to diabetic rats. Acta Biomater. 2013;9:8952–61.CrossRefGoogle Scholar
  19. 19.
    Ma YZ, Boese SE, Luo Z, Nitin N, Gill HS. Drug coated microneedles for minimally-invasive treatment of oral carcinomas: development and in vitro evaluation. Biomed Microdevices. 2015;17:44.CrossRefGoogle Scholar
  20. 20.
    Chu LY, Choi SO, Prausnitz MR. Fabrication of dissolving polymer microneedles for controlled drug encapsulation and delivery: bubble and pedestal microneedle designs. J Pharm Sci. 2010;99:4228–38.CrossRefGoogle Scholar
  21. 21.
    Guo L, Chen JM, Qiu YQ, Zhang SH, Xu B, Gao YH. Enhanced transcutaneous immunization via dissolving microneedle array loaded with liposome encapsulated antigen and adjuvant. Int J Pharm. 2013;447:22–30.CrossRefGoogle Scholar
  22. 22.
    DeMuth PC, Min Y, Irvine DJ, Hammond PT. Implantable silk composite microneedles for programmable vaccine release kinetics and enhanced immunogenicity in transcutaneous immunization. Adv Healthc Mater. 2014;3:47–58.CrossRefGoogle Scholar
  23. 23.
    Sullivan SP, Murthy N, Prausnitz MR. Minimally invasive protein delivery with rapidly dissolving polymer microneedles. Adv Mater. 2008;20:933–8.CrossRefGoogle Scholar
  24. 24.
    McCrudden MTC, Alkilani AZ, McCrudden CM, McAlister E, McCarthy HO, Woolfson AD, et al. Design and physicochemical characterisation of novel dissolving polymeric microneedle arrays for transdermal delivery of high dose, low molecular weight drugs. J Control Release. 2014;180:71–80.CrossRefGoogle Scholar
  25. 25.
    Wang S, Jia ZX, Zhou XY, Zhou DB, Chen MZ, Xie D, et al. J Appl Polym Sci. 2017;134:8.Google Scholar
  26. 26.
    Laha A, Sharma CS, Majumdar S. Mater Sci Eng C Mater Biol Appl. 2017;76:782–6.CrossRefGoogle Scholar
  27. 27.
    Wang QL, Zhu DD, Chen Y, Guo XD. A fabrication method of microneedle molds with controlled microstructures. Mater Sci Eng C-Mater Biol Appl. 2016;65:135–42.CrossRefGoogle Scholar
  28. 28.
    Zhu DD, Wang QL, Liu XB, Guo XD. Rapidly separating microneedles for transdermal drug delivery. Acta Biomater. 2016;41:312–9.CrossRefGoogle Scholar
  29. 29.
    Zhu DD, Chen BZ, He MC, Guo XD. Structural optimization of rapidly separating microneedles for efficient drug delivery. J Ind Eng Chem. 2017;51:178–84.CrossRefGoogle Scholar

Copyright information

© Controlled Release Society 2019

Authors and Affiliations

  1. 1.Beijing Laboratory of Biomedical Materials, College of Materials Science and EngineeringBeijing University of Chemical TechnologyBeijingPeople’s Republic of China
  2. 2.Department of DermatologyChina-Japan Friendship HospitalBeijingPeople’s Republic of China

Personalised recommendations